Skip to Content

Zanamivir Pregnancy and Breastfeeding Warnings

Zanamivir is also known as: Relenza

Zanamivir Pregnancy Warnings

Zanamivir has been assigned to pregnancy category C by the FDA. High-dose animal studies have failed to reveal evidence of embryotoxicity, teratogenicity, or maternal toxicity. Another high-dose study (1000 times the human exposure) found minor skeletal changes and variants; however, the incidence was not significantly different than the background incidence for the strain. Although zanamivir has been shown to cross the placenta in animal studies, drug concentrations in fetal blood have been significantly lower than those in maternal blood. There are no controlled data in human pregnancy. Zanamivir should only be given during pregnancy when benefit outweighs risk.

See references

Zanamivir Breastfeeding Warnings

There are no data on the excretion of zanamivir into human milk. Zanamivir is excreted into the milk of rats.

See references

References for pregnancy information

  1. "Product Information. Relenza (zanamivir)" Glaxo Wellcome, Research Triangle Pk, NC.
  2. "Antiviral drugs prophylaxis and treatment of influenza." Med Lett Drugs Ther 48 (2006): 87-8

References for breastfeeding information

  1. "Product Information. Relenza (zanamivir)" Glaxo Wellcome, Research Triangle Pk, NC.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.